Q/C Technologies, Inc. (QCLS) SEC Filings — 2025
18 SEC filings for Q/C Technologies, Inc. (QCLS) in 2025.
Filings
- Q/C Technologies, Inc. 8-K Filing — 8-K · Dec 9, 2025
- QCLS Cash Surges on New Capital, Net Loss Narrows to $5.7M — 10-Q · Nov 19, 2025
- Q/C Technologies Files 8-K: Officer/Director Changes & Shareholder Votes — 8-K · Nov 14, 2025
- QCLS Seeks Shareholder Nod for Dilutive Issuances, Reverse Split — DEF 14A · Oct 20, 2025
- Q/C Technologies Files 8-K/A Amendment — 8-K/A · Oct 6, 2025
- Q/C Technologies, Inc. Files 8-K: Material Agreements & Equity Changes — 8-K · Oct 3, 2025
- Q/C Technologies Files 8-K with Bylaw Amendments — 8-K · Sep 26, 2025
- TNF Pharmaceuticals Files 8-K: Material Agreement & Bylaw Changes — 8-K · Sep 10, 2025
- TNF Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Sep 5, 2025
- TNF Pharmaceuticals Announces Material Agreements & Officer Changes — 8-K · Sep 2, 2025
- TNF Pharmaceuticals Files Q2 2025 10-Q — 10-Q · Aug 19, 2025
- TNF Pharmaceuticals Holds Shareholder Vote on Reverse Split — 8-K · Jun 6, 2025
- TNF Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 15, 2025
- TNF Pharmaceuticals Files 8-K for Bylaw Amendments & Exhibits — 8-K · May 9, 2025
- TNF Pharmaceuticals Files 2024 DEF 14A — DEF 14A · Apr 21, 2025
- TNF Pharmaceuticals Files 2024 10-K, Details Preferred Stock — 10-K · Apr 11, 2025
- TNF Pharmaceuticals Faces Delisting Concerns — 8-K · Mar 21, 2025
- TNF Pharmaceuticals Files 8-K Report — 8-K · Mar 10, 2025